CLINICAL_TRIALS
trial_result
· 2019-03-13
Clinical Trial Update: A Safety and Efficacy Study to Evaluate AMG 334 in Migraine Prevention [Phase 2]
Summary
Phase 2 trial update for AMG 334 in migraine prevention has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Migraine | Phase 2 | Status: COMPLETED | Results posted: 2019-03-13